BioAmber's biggest problem is that they filed for bankruptcy. There was no agreement to merge with anyone. There is no BOD, CEO, or even a secretary to answer the phones. Technically discharged, the case is closed. The residual actions is just that... residual. There is no one from BioAmber to petition FINRA to unsuspend the company, therefore it will stay suspended until final word. This will never trade again. There is no if and or buts. A new CUSIP will have to be issued but again, there is no one in BioAmber to file or do any forms required. Since there is no merger, once BK is final, the SEC could revoke the registration making it permanent. No one will rebut that action since there is no one left. Revocation of registration means there are no shares left...poof! This is pretty straight forward since it was suspended due to Chap 15 processing which could be translated as a Chap 7 BK as well. Anyone can argue their point until the cows come home, but the bottomline is, this is not trading, not even in the Grey Market...period.
Dragon52